Tony Chan

tony-chan

Tony Chan

Partner

Washington, D.C. | 1900 K Street, NW, Washington, DC 20006-1110
+1 202 261 3388 | +1 202 261 3333

Boston | One International Place, 40th Floor, 100 Oliver Street, Boston, MA 02110-2605
+1 617 728 7189 | +1 617 426 6567

| vCard | PDF

Tony Chan advises strategic buyers and sellers as well as financial sponsors and their portfolio companies in complex corporate transactions, including significant experience with international and cross-border matters. Mr. Chan focuses his practice on mergers and acquisitions, including private equity and growth equity transactions, as well as corporate finance, emerging company formation and financing, public company governance and general corporate matters for clients with an emphasis in the life sciences, financial services and technology sectors.

In addition to his practice, he is an adjunct professor at Georgetown Law School where he teaches Mergers and Acquisitions and serves on the steering committee for the Corporate and Securities community of the DC Bar and the boards of the Arlington Arts Center and the Harvard Law School Association of DC.

Mr. Chan acts as pro bono counsel to a number of nonprofit organizations, including Aequitas, APAI Vote, Rebuilding Together Philadelphia, Philadelphia Film Society and Kangu, and charter schools, including Rocketship Education and North Star.

Tony Chan has been named one of a select number of "Next Generation Lawyers" for Life Sciences in the United States by the 2017 edition of leading legal referral guide The Legal 500 and "highly recommended" for his work in the sector. In 2016, Mr. Chan was also named one of Law360's Rising Stars for Life Sciences, which recognizes attorneys under 40 who have demonstrated outstanding career accomplishments. In particular, Law360 highlighted his expertise navigating the complex life sciences industry and key partnership negotiations between biotechnology and drug companies. In addition, Mr. Chan was recently recognized as a Rising Star for both M&A and private equity in IFLR1000 and as one of Legal Media Group's Rising Stars for corporate/M&A.

Significant Representations

Examples of recent transactions on which Mr. Chan has counseled include:

Life Sciences

  • Celgene Corporation on numerous transactions, including its:
    • collaboration with Jounce Therapeutics, Inc. and related equity investment;
    • collaboration with Juno Therapeutics, Inc. and a related acquisition of a 10% stake for US$1 billion;
    • collaboration with Nurix, Inc.;
    • multiple collaborations with Sutro BioPharma;
    • multiple collaborations with Forma Therapeutics Holdings, LLC;
    • collaboration with OncoMed;
    • investment in Epizyme, Inc. and 
    • acquisition of Avila Therapeutics for US$350 million in cash, plus up to an additional US$575 million in CVRs.
  • Ipsen S.A. in connection with its acquisition of global oncology assets from Merrimack Pharmaceuticals for up to US$1 billion.
  • Ferring Pharmaceuticals on its:
    • acquisition of Cytokine PharmaSciences Inc. and Controlled Therapeutics (Scotland) Ltd.;
    • acquisition of Lysteda, a pharmaceutical product indicated for the treatment of menorrhagia, from Xanodyne Pharmaceuticals, Inc.;
    • acquisition of DDAVP from Sanofi;
    • acquisition of the global rights to Milprosa from Teva Women’s Health, Inc.; and
    • acquisition of two phase III ready orthobiologic product candidates from BioSurface Engineering Technologies Inc.
  • R-Pharm US in its acquisition of the breast cancer drug Ixempra from Bristol-Myers Squibb. 
  • Orexo AB in its sale of its rights to Abstral in the United States to Galena Biopharma, Inc.
  • Lumara Health Inc. in its sale in two separate transactions for up to US$1.1 billion.
  • Intezyne, a clinical-stage company developing novel anti-cancer therapies, in a series of financing transactions.
  • Cornerstone Therapeutics in its acquisition of Cardiokine Inc., a specialty pharmaceutical company focused on developing products for cardiovascular indications.
  • Paul Capital Partners in its sale of Timm Medical Technologies, Inc. to Actient Pharmaceuticals.
  • Topotarget A/S in its sale of the pharmaceutical products Savene to SpePharm Holding B.V. and Totect to Apricus Biosciences.
  • Covance Inc. in its acquisition of the Gene Expression Laboratory from Merck.
  • Tekla Capital Management in a broad range of investments in private biotechnology companies.

Financial Services

  • Guggenheim Investments in its acquisition of Accretive Asset Management LLC.
  • Ameriprise Financial in its sale of the retail custodial and transfer agency businesses and acquisition of Emerging Global Advisers, LLC.
  • Innovatus Capital Partners in its formation and establishment of operations.
  • Marble Point Credit Management in its acquisition of American Capital CLO Management, LLC.
  • Pretium Capital Management in its acquisition of Valcour Capital Management, LLC
  • RCS Capital Corporation in its sale of Hatteras Funds, LLC to Raleigh Acquisition, LLC.
  • William Blair & Company in its acquisition of hedge fund-of-funds firm Guidance Capital, LLC.
  • Horizons ETFs Management (USA) LLC is its acquisition of Recon Capital Management, LLC.
  • Fifth Street CLO Management in its sale of Fifth Street CLO Management LLC to Newstar Financial, Inc.
  • Manulife Asset Management in its acquisition of Optique Capital Management, LLC.
  • Ashmore in its acquisition of Dolomite Capital Management, LLC.
  • FSI Capital in its Acquisition of ACA's asset management business. 
  • State Street Global Advisors in its sale of Shott Capital Management to Hamilton Lane Advisors.
  • Dividend Capital Advisors in its sale of certain assets of Virtus Investment Partners.
  • Ticonderoga in its acquisition of Reynders, Gray & Co. and Soleil Securities. 
  • A10 Capital, LLC in its sale of a minority interest to H.I.G. Capital.

Technology

  • Stripes Group, a leading growth equity firm, in a number of its investments, including in: Art.com, Audionetwork, BlackTux, Blue Apron, BookMyShow, Califia Farms, Craftsy, eMarketer, Flatiron Health, Gimlet Media, GoFundMe, GrubHub, Kareo, Ketra Lighting, MyWebGrocer, Netbiscuits, Pond5, Refinery29, Reformation, Remitly, Sandata, SPINS, Stella & Chewy’s, Turtle Beach, Udemy and Upwork.
  • Turtle Beach Corporation in its acquisition of Parametric Sound Corporation. 
  • MyWebGrocer, a provider of digital grocery solutions, in its sale to HGGC.
  • The management team of Getty Images, Inc. in the US$2.4 billion acquisition of Getty Images by Hellman & Friedman.
  • Gilat Satellite Networks in its sale of SpaceNet, Inc. to SageNet.
  • Special committee of the board of directors of XO Holdings, Inc. in connection with the acquisition of XO Holdings by ACF Industries Holding Corp., an entity wholly owned by Carl Icahn.
  • Versa Capital Management, Inc. in its acquisition of Allen-Vanguard Corporation.
Education
  • Harvard Law School, J.D., 2003
  • Tulane University, B.A., 2000, magna cum laude
Admissions
  • District of Columbia
  • New York
  • Massachusetts
  • Supreme Court of the United States